Lorraine M Fathers

Author PubWeight™ 12.22^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia.	N Engl J Med	2009	5.79
2	Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses.	Proc Natl Acad Sci U S A	2010	1.67
3	Induction of p53-specific immunity by a p53 synthetic long peptide vaccine in patients treated for metastatic colorectal cancer.	Clin Cancer Res	2009	1.27
4	HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial.	J Transl Med	2013	1.02
5	A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions.	Cancer Immunol Immunother	2012	0.97
6	The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study.	Cancer Immunol Immunother	2013	0.89
7	Addition of interferon-α to the p53-SLP® vaccine results in increased production of interferon-γ in vaccinated colorectal cancer patients: a phase I/II clinical trial.	Int J Cancer	2012	0.88